Through our own work and in partnerships, we accelerate healthcare innovation by transforming promising life science ideas into life-changing medical breakthroughs for patients.

NEWS
LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2

AstraZeneca granted exclusive worldwide licence to develop, manufacture and commercialise RQ Bio’s existing early-stage monoclonal antibodies (mAbs) against SARS-CoV-2 and right to exclusively licence additional mAbs against SARS-CoV-2 RQ Bio launched to develop treatments and preventative therapies based on potent broad spectrum mAbs to provide instant and long-lasting immunity for vulnerable people at risk of […]
NEWS
Pandemic Science Hub to develop better drugs to fight lung disease
Action Medical Research and LifeArc announce another round of funding
LifeArc and Scottish Government work together to drive Scottish research
Study reveals gene faults underpinning severe Covid-19
LifeArc elects new Board Chair to drive charity’s ambitious strategy
New study explores unique approach to treat a rare liver disease
Celebrating our inspirational women scientists
LifeArc bolsters scientific leadership by appointing new Chief Scientific Office
Reflecting on 2021 – a year of progress
Researchers
We can help to fund, develop and protect your academic research.
Working with TTOs
Our IP management skills can help protect and develop your medical research
Early ventures funding
Funding innovations with the potential to change lives
Diagnostics development
Collaborative diagnostics development and validation
Drug discovery
As a charity we want to make sure your research reaches patients and minimise cost and risk for you
Case study
LifeArc supports MRC spin-out to Series A funding
How we supported scientists to progress a technology from the lab to the point where it is ready to move towards the clinic
Charities
By working together we can increase our impact.
Helping charities
We help fellow charities fund, resource and develop medical research
Our partners
Through collaboration we give promising research every chance to succeed
Case study
Alliance enables clinical trial of experimental treatment for epidermolysis bullosa
Collaboration with four EB charities from three different countries
Industry
We work with you to develop potential projects.
Licensing opportunities
Projects and products available for partnering and collaboration
In vitro diagnostics
Partner with us on diagnostic development
Antibody engineering
Our antibody engineering expertise has helped to put humanised antibody drugs on the market
Case study
Keytruda: a new generation cancer treatment
Humanised antibody known as Keytruda (pembrolizumab)
My Interest
Academic Scientist
Pharma/Biotech
Medical Charity
MRC Scientist
Research Organisation